CXCL9 emerges as a promising biomarker for primary Sjögren’s syndrome with extra-glandular manifestations
In a recent publication featured in Arthritis Research & Therapy, CXCL9 emerges as a pivotal biomarker for primary Sjögren’s syndrome (pSS), demonstrating remarkable efficacy in distinguishing between pSS patients with and without extra-glandular manifestations (EGM). Hong and colleagues utilized advanced RNA sequencing techniques to analyze gene expression profiles in the minor salivary glands (MSG) of … Read more